Solution Behavior of PVP-VA and HPMC-AS-Based Amorphous Solid Dispersions and Their Bioavailability Implications

Solubility Advantage of Amorphous Pharmaceuticals, Part 3: Is Maximum Solubility Advantage Experimentally Attainable and Sustainable?

(2011) Sharad B. Murdande et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

The influence of crystallization inhibition of HPMC and HPMCAS on model substance dissolution and release in swellable matrix tablets

(2010) Farhad Tajarobi et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

A biorelevant dissolution stress test device – background and experiences

(2010) Grzegorz Garbacz et al.   Expert Opinion on Drug Delivery

Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion?

(2010) Feng Qian et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Solubilities of Crystalline Drugs in Polymers: An Improved Analytical Method and Comparison of Solubilities of Indomethacin and Nifedipine in PVP, PVP/VA, and PVAc

(2010) Ye Sun et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Drug–Polymer Solubility and Miscibility: Stability Consideration and Practical Challenges in Amorphous Solid Dispersion Development

(2010) Feng Qian et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Review: physical chemistry of solid dispersions

(2010) Sandrien Janssens et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Dissolution Rate and Apparent Solubility of Poorly Soluble Drugs in Biorelevant Dissolution Media

(2010) Jonas H. Fagerberg et al.   MOLECULAR PHARMACEUTICS

Quantitative Analysis of the Effect of Supersaturation on in Vivo Drug Absorption

(2010) Ryusuke Takano et al.   MOLECULAR PHARMACEUTICS

Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution

(2010) David E. Alonzo et al.   PHARMACEUTICAL RESEARCH

Correlating thermodynamic and kinetic parameters with amorphous stability

(2009) Kirsten A. Graeser et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Novel methods for the assessment of miscibility of amorphous drug-polymer dispersions

(2009) Igor Ivanisevic et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Analysis of Nifedipine Absorption from Soft Gelatin Capsules Using PBPK Modeling and Biorelevant Dissolution Testing

(2009) Kirstin Thelen et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone)

(2009) Patrick J. Marsac et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis

(2009) Sharad B. Murdande et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Utility of Hydroxypropylmethylcellulose Acetate Succinate (HPMCAS) for Initiation and Maintenance of Drug Supersaturation in the GI Milieu

(2009) William Curatolo et al.   PHARMACEUTICAL RESEARCH

Effects of Polymer Type and Storage Relative Humidity on the Kinetics of Felodipine Crystallization from Amorphous Solid Dispersions

(2009) Alfred C. F. Rumondor et al.   PHARMACEUTICAL RESEARCH

Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine

(2008) Hajime Konno et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Characterization of amorphous API:Polymer mixtures using X-ray powder diffraction

(2008) Ann Newman et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview

(2008) Dwayne T. Friesen et al.   MOLECULAR PHARMACEUTICS

Solubility of Small-Molecule Crystals in Polymers: d-Mannitol in PVP, Indomethacin in PVP/VA, and Nifedipine in PVP/VA

(2008) Jing Tao et al.   PHARMACEUTICAL RESEARCH